JPH01305098A - ペプチド誘導体 - Google Patents

ペプチド誘導体

Info

Publication number
JPH01305098A
JPH01305098A JP1090507A JP9050789A JPH01305098A JP H01305098 A JPH01305098 A JP H01305098A JP 1090507 A JP1090507 A JP 1090507A JP 9050789 A JP9050789 A JP 9050789A JP H01305098 A JPH01305098 A JP H01305098A
Authority
JP
Japan
Prior art keywords
formula
hydrogen
residue
tables
formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1090507A
Other languages
English (en)
Japanese (ja)
Inventor
Rainer Albert
ライネル・アルベルト
Wilfried Bauer
ビルフリート・バウエル
Francois Cardinaux
フランソワ・カルディノ
Janos Pless
ヤノス・プレス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808442A external-priority patent/GB8808442D0/en
Priority claimed from GB888826452A external-priority patent/GB8826452D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPH01305098A publication Critical patent/JPH01305098A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP1090507A 1988-04-11 1989-04-10 ペプチド誘導体 Pending JPH01305098A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888808442A GB8808442D0 (en) 1988-04-11 1988-04-11 Peptide derivatives
GB8808442.1 1988-04-11
GB8826452.8 1988-11-11
GB888826452A GB8826452D0 (en) 1988-11-11 1988-11-11 Peptide derivatives

Publications (1)

Publication Number Publication Date
JPH01305098A true JPH01305098A (ja) 1989-12-08

Family

ID=26293760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1090507A Pending JPH01305098A (ja) 1988-04-11 1989-04-10 ペプチド誘導体

Country Status (14)

Country Link
JP (1) JPH01305098A (enrdf_load_html_response)
AU (1) AU3263989A (enrdf_load_html_response)
BE (1) BE1003200A4 (enrdf_load_html_response)
CH (1) CH677795A5 (enrdf_load_html_response)
DE (1) DE3910667A1 (enrdf_load_html_response)
DK (1) DK171489A (enrdf_load_html_response)
ES (1) ES2013431A6 (enrdf_load_html_response)
FR (1) FR2629824B1 (enrdf_load_html_response)
GB (1) GB2224280B (enrdf_load_html_response)
IL (1) IL89897A0 (enrdf_load_html_response)
IT (1) IT1231943B (enrdf_load_html_response)
LU (1) LU87496A1 (enrdf_load_html_response)
NL (1) NL8900882A (enrdf_load_html_response)
SE (1) SE8901278L (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100325972B1 (ko) * 1993-08-09 2002-07-27 바이오메져 인코퍼레이티드 치료성펩타이드유도체
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components

Also Published As

Publication number Publication date
FR2629824A1 (fr) 1989-10-13
LU87496A1 (fr) 1989-11-14
DK171489D0 (da) 1989-04-10
NL8900882A (nl) 1989-11-01
GB2224280B (en) 1992-07-08
IT1231943B (it) 1992-01-16
DE3910667A1 (de) 1989-10-19
DK171489A (da) 1989-10-12
IT8947833A0 (it) 1989-04-10
CH677795A5 (enrdf_load_html_response) 1991-06-28
SE8901278D0 (sv) 1989-04-10
AU3263989A (en) 1989-10-12
GB2224280A (en) 1990-05-02
FR2629824B1 (fr) 1995-03-10
ES2013431A6 (es) 1990-05-01
IL89897A0 (en) 1989-12-15
GB8907902D0 (en) 1989-05-24
SE8901278L (sv) 1989-10-12
BE1003200A4 (fr) 1992-01-14

Similar Documents

Publication Publication Date Title
US4684620A (en) Cyclic polypeptides having mu-receptor specificity
US4328214A (en) Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
FR2677361A1 (fr) Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US4603120A (en) Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
JPH04504723A (ja) 線状ソマトスタチン類似体
FR2501199A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
PL169498B1 (pl) Sposób wytwarzania nowych zwiazków polipeptydowych PL PL
JPH04505456A (ja) ６位にスレオニンを有するソマトスタチン類縁体オクタペプチド
UA34456C2 (uk) Пептид, який має активність антагоніста бомбезину, фармацевтична композиція на його основі і спосіб лікування раку у ссавців
JPS6261997A (ja) 治療用ソマトスタチン同族体
NZ225188A (en) Somatostatin derivatives and pharmaceutical compositions
US5620959A (en) Bombesin antagonists
JPH0242026A (ja) 関節炎の処置
TW575582B (en) Somatostatin antagonists
JPH05124979A (ja) ソマトスタチンペプチド類の治療用途
RU2160741C2 (ru) Соматостатиновые пептиды
JPH01305098A (ja) ペプチド誘導体
EP0044451B1 (en) Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
AU2004251866B2 (en) Pharmaceutical composition comprising cyclic somatostatin analogues
JP2001518515A (ja) リウマチ性関節炎の治療組成物および治療方法
JPH0615558B2 (ja) 新規ポリペプチド、その製造法および医薬
PT100111B (pt) Composicao para o tratamento de um mamifero sofrendo de doenca proliferativa dapele, benigna ou maligna, compreendendo um analogo de somatostatina
EP0117447B1 (de) Cyclische Peptide mit Somatostatin-Wirkung
IE912671A1 (en) Peptides
GB2227488A (en) Modified somatostatin